Literature DB >> 28587386

SOCS3 overexpression inhibits advanced glycation end product-induced EMT in proximal tubule epithelial cells.

Lin Yu1,2,3, Ying Zhang4, Huimin Zhang1,2,3, Yingtao Li1,2,3.   

Abstract

Diabetic nephropathy (DN) is among the most severe complications of diabetes mellitus, and may lead to end-stage renal disease. Sustained exposure to advanced glycation end products (AGEs) typically causes renal tubular epithelial cells (TECs) to suffer from an epithelial-to-mesenchymal transition (EMT). However, there remains no consensus regarding the mechanism underlying the cause of EMT in TECs as induced by AGEs. In the present study, we investigated the promotion of EMT in TECs by AGEs, and the activation of Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling. In addition, we constructed a recombinant adenovirus (Ad) that overexpressed suppressor of cytokine signaling 3 (SOCS3), and examined the regulatory role of SOCS3 in the activation of JAK/STAT signaling and the promotion of EMT in TECs. The results demonstrated that AGE-bovine serum albumin (BSA) treatment significantly promoted the expression of EMT-associated proteins, while reducing the expression of the epithelial cell marker, E-cadherin. Furthermore, the Ad-mediated SOCS3 overexpression markedly inhibited the AGE-BSA-induced JAK2/STAT3 activation; phosphorylated JAK2 and phosphorylated STAT3 expression levels were reduced by the Ad-SOCS3 infection, compared with the control Ad (Ad-con) infection, in HK-2 cells subject to AGE-BSA. Moreover, the overexpression of SOCS3 markedly inhibited the AGE-BSA-promoted EMT in HK-2 cells. AGE-BSA-promoted EMT-associated proteins, such as α-smooth muscle actin and collagen I, were reduced by the Ad-SOCS3 virus infection, in contrast to the Ad-con virus infection. Furthermore, reduced E-cadherin expression was reversed by the Ad-SOCS3 virus infection, in contrast to the Ad-con virus infection, in epithelial HK-2 cells. In conclusion, the present study confirmed the inhibitory role of SOCS3 in the AGE-induced EMT in renal TECs, implying the protective role of SOCS3 in DN.

Entities:  

Keywords:  Janus kinase/signal transducers and activators of transcription; advanced glycation end products; epithelial-to-mesenchymal transition; suppressor of cytokine signaling 3

Year:  2017        PMID: 28587386      PMCID: PMC5450738          DOI: 10.3892/etm.2017.4297

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  40 in total

1.  Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.

Authors:  J S Huang; J Y Guh; W C Hung; M L Yang; Y H Lai; H C Chen; L Y Chuang
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

2.  Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells.

Authors:  C Min; E Kang; S H Yu; S H Shinn; Y S Kim
Journal:  Diabetes Res Clin Pract       Date:  1999-12       Impact factor: 5.602

3.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 4.  Advanced glycation end products: sparking the development of diabetic vascular injury.

Authors:  Alison Goldin; Joshua A Beckman; Ann Marie Schmidt; Mark A Creager
Journal:  Circulation       Date:  2006-08-08       Impact factor: 29.690

5.  Suppressors of cytokine signaling abrogate diabetic nephropathy.

Authors:  Guadalupe Ortiz-Muñoz; Virginia Lopez-Parra; Oscar Lopez-Franco; Paula Fernandez-Vizarra; Beñat Mallavia; Claudio Flores; Ana Sanz; Julia Blanco; Sergio Mezzano; Alberto Ortiz; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 10.121

6.  The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster.

Authors:  H P Hammes; B Wellensiek; I Klöting; E Sickel; R G Bretzel; M Brownlee
Journal:  Diabetologia       Date:  1998-02       Impact factor: 10.122

Review 7.  Diabetic nephropathy: mechanisms of renal disease progression.

Authors:  Yashpal S Kanwar; Jun Wada; Lin Sun; Ping Xie; Elisabeth I Wallner; Sheldon Chen; Sumant Chugh; Farhad R Danesh
Journal:  Exp Biol Med (Maywood)       Date:  2008-01

Review 8.  Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure.

Authors:  Masaomi Nangaku
Journal:  Intern Med       Date:  2004-01       Impact factor: 1.271

Review 9.  Role of the JAK/STAT signaling pathway in diabetic nephropathy.

Authors:  Mario B Marrero; Amy K Banes-Berceli; David M Stern; Douglas C Eaton
Journal:  Am J Physiol Renal Physiol       Date:  2006-04

10.  Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes.

Authors:  P J Beisswenger; Z Makita; T J Curphey; L L Moore; S Jean; T Brinck-Johnsen; R Bucala; H Vlassara
Journal:  Diabetes       Date:  1995-07       Impact factor: 9.461

View more
  3 in total

1.  Methylglyoxal-derived advanced glycation end products induce matrix metalloproteinases through activation of ERK/JNK/NF-κB pathway in kidney proximal epithelial cells.

Authors:  So-Ra Jeong; Ho-Young Park; Yoonsook Kim; Kwang-Won Lee
Journal:  Food Sci Biotechnol       Date:  2019-11-28       Impact factor: 2.391

2.  LncRNA-miRNA-mRNA expression variation profile in the urine of calcium oxalate stone patients.

Authors:  Xiongfa Liang; Yongchang Lai; Weizhou Wu; Dong Chen; Fangling Zhong; Jian Huang; Tao Zeng; Xiaolu Duan; Yapeng Huang; Shike Zhang; Shujue Li; Wenqi Wu
Journal:  BMC Med Genomics       Date:  2019-04-29       Impact factor: 3.063

3.  lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer.

Authors:  Bingyan Liu; Shaoqiu Wu; Jun Ma; Shuo Yan; Zhengguang Xiao; Linhuang Wan; Feng Zhang; Mingyi Shang; Aiwu Mao
Journal:  Mol Ther Nucleic Acids       Date:  2018-10-06       Impact factor: 8.886

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.